Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103794.pdf 0001193125-20-103794.rtf 0001193125-20-103794.xls View HTML
April 9, 2020	SC 13G/A	An amendment to the SC 13G filing	0001567619-20-007748.pdf 0001567619-20-007748.rtf 0001567619-20-007748.xls View HTML
April 8, 2020	8-K	Report of unscheduled material events or corporate event	0001564590-20-015926.pdf 0001564590-20-015926.rtf 0001564590-20-015926.xls View HTML
April 7, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-100000.pdf 0001193125-20-100000.rtf 0001193125-20-100000.xls View HTML
April 7, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-002937.pdf 0001562180-20-002937.rtf 0001562180-20-002937.xls View HTML
April 7, 2020	3	Initial filing by director officer or owner of more than ten percent.	0001562180-20-002936.pdf 0001562180-20-002936.rtf 0001562180-20-002936.xls View HTML
March 12, 2020	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-20-010491.pdf 0001564590-20-010491.rtf 0001564590-20-010491.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 12, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001193125-20-071680.pdf 0001193125-20-071680.rtf View HTML
March 12, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-071688.pdf 0001193125-20-071688.rtf 0001193125-20-071688.xls View HTML
March 10, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-067865.pdf 0001193125-20-067865.rtf 0001193125-20-067865.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax